COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 11, 2021
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Are Biologics for COPD Around the Corner? A Quick Look at the Literature
No biologic agent is approved to treat COPD, but progress is being made. Key developments of the past few years are summarized in this brief slideshow.
The Migraine Research Renaissance and Where it is Headed: A PI Interview
New and highly specific migraine drugs have significantly changed the clinical landscape for patients. We talked with Peter McAllister, MD, about where the research goes next.
COVID-19 Disruption: America’s Outlook is Complicated
What do US adults think about the disruption COVID-19 has had on their lives? Do they see the pandemic improving in the coming months? A recent Gallup poll offers insight.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 10, 2021
Eli Lilly’s Tirzepatide Significantly Reduced A1c, Body Weight in Adults with T2D
Results from a head-to-head study show the investigational medication, tirzepatide, led to superior A1c and body weight reductions compared to semaglutide.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 9, 2021
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, and more.
CDC Lifts Masking, Distancing Requirements for Fully Vaccinated Individuals
The CDC on March 8, 2021, lifted some COVID-19 restrictions for fully vaccinated Americans, including the need for a mask and social distancing in certain situations.
Patients with PAH-COPD May be at Higher Risk than those with Idiopathic PAH
Transplant-free survival was found lower among patients with pulmonary hypertension-COPD than among those with IPAH in a new study published in CHEST.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 8, 2021
US confirmed cases of COVID-19 have surpassed 29 million; global cases have reached 117 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Routine Adult Vaccination Rates Still Low: Slow Post-lockdown Rebound
Routine adult vaccination rates have yet to reach pre-pandemic levels, according to a report in MMWR this week. Which vaccines are most affected and which groups are lagging?
AAAAI 2021: Asthma Not an Independent Predictor of Severe COVID-19 Outcomes
Recent research presented at AAAAI 2021 Virtual Annual Meeting suggests asthma is not an independent risk factor for severe COVID-19 or hospitalization.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 5, 2021
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
Increase in Abdominal Fat Linked to Greater Heart Disease Risk in Menopause
A new study suggests that women who experience an accelerated accumulation of abdominal fat during menopause are at greater risk of heart disease, even if their weight stays steady.
Semaglutide Associated with Substantial Weight Loss in Patients with Obesity
More than half of adults with obesity who received once-weekly semaglutide lost 15% of body weight, according to the recently published STEP 1 study.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 4, 2021
Global confirmed cases of COVID-19 have surpassed 115 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
ID Expert Talks about the Year that Brought Us the COVID-19 Vaccine
The COVID-19 vaccine development story of 2020 was the focus when infectious disease specialist and AIDS researcher Dr Rodger MacArthur spoke with Patient Care Online in January.
Safest US States during COVID-19: Data on Transmission, Positive Testing, Hospitalizations, & More
Which states have the highest vaccination rates? What about the lowest death rate? Results from a recent nationwide comparison on the safest states during COVID-19 shed light.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 3, 2021
UK: Pfizer, AstraZeneca COVID-19 Vaccines Effective in Reducing Infections in Older Patients
New real-world data from England suggests that the Oxford-AstraZeneca and Pfizer-BioNTech COVID-19 vaccines are highly effective in reducing infections among older patients.
